SCHEMBL18770536

SCHEMBL18770536

COC(=O)Cc1nn(C)c(O)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 1/20 0.37
HSP90AB1 P08238 1/20 0.37
GAA P10253 5/20 0.35
HTT P42858 2/20 0.33
HSD17B10 Q99714 2/20 0.33
KDM4E B2RXH2 4/20 0.32
ALDH1A1 P00352 3/20 0.32
USP2 O75604 1/20 0.32
GFER P55789 1/20 0.32
CYP4F2 P78329 1/20 0.32
CYP4A11 Q02928 1/20 0.32
LMNA P02545 3/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MAPK1 P28482 1/20 0.32
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13799640 0.84 SMN1; SMN2 (0.39) SMN1; SMN2MAPTHSP90AB1GAAHTT
SCHEMBL18770506 0.79 MAPT (0.35) SMN1; SMN2MAPTHSP90AB1GAAHTT
SCHEMBL13799632 0.75 SMN1; SMN2 (0.38) SMN1; SMN2MAPTHSP90AB1GAAHTT
SCHEMBL13799635 0.75 SMN1; SMN2 (0.38) SMN1; SMN2MAPTHSP90AB1GAAHTT
SCHEMBL23399071 0.71 GAA (0.55) GAAGFER
SCHEMBL23398526 0.69 GAA (0.36) SMN1; SMN2GAAHTTALDH1A1NPC1
SCHEMBL8653944 0.69 KDM4E (0.38) SMN1; SMN2MAPTHSP90AB1GAAHTT
SCHEMBL13807673 0.69 ALDH1A1 (0.56) SMN1; SMN2MAPTGAAHTTKDM4E
SCHEMBL14564363 0.68 SMN1; SMN2 (0.44) SMN1; SMN2MAPTGAAHTTHSD17B10
SCHEMBL19585733 0.68 SMN1; SMN2 (0.53) SMN1; SMN2MAPTGAAHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108473439-B Pyrazolone derivatives as nitroxyl donors 卡尔迪奥克斯尔制药公司 2022-03-15 CN disclosed
US-10723704-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2020-07-28 US disclosed
US-10723704-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2020-07-28 US disclosed
US-20180318308-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. 2018-11-08 US disclosed
EP-3365328-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals, Inc. (US) 2018-08-29 EP disclosed
WO-2017070081-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-04-27 WO disclosed
WO-2017070081-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-04-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10723704-B2 Pyrazolone derivatives as nitroxyl donors TNNI3, PFKP, NOX5 SMN1; SMN2 1078/4885MAPT 3895/4885HSP90AB1 1292/4885
US-20180318308-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 SMN1; SMN2 1078/4885MAPT 3895/4885HSP90AB1 1292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.